help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 17, 2007
Molecular Endocrinology, doi:10.1210/me.2007-0089
Molecular Endocrinology Vol. 0, No. 2007 200700891-
doi:10.1210/me.2007-0089
Copyright © 2007 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
21/6/1359    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hubbert, M. L.
Right arrow Articles by Edwards, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hubbert, M. L.
Right arrow Articles by Edwards, P. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL

Submitted on February 16, 2007
Accepted on April 9, 2007

Regulation of Hepatic Insig-2 by the Farnesoid X-receptor

Melissa L. Hubbert, Yanqiao Zhang, Florence Y. Lee, and Peter A. Edwards*

Departments of Biological Chemistry and Medicine, David Geffen School of Medicine, and the Molecular Biology Institute at UCLA, Los Angeles, CA 90095

* To whom correspondence should be addressed. E-mail: pedwards{at}mednet.ucla.edu.

Activation of the farnesoid X-receptor (FXR{alpha}) affects genes controlling many pathways, including those involved in bile acid and glucose homeostasis. Here we report that a critical gene involved in cholesterol homeostasis, Insig-2, was induced when mice or cultured cells were treated with FXR{alpha} agonists or infected with constitutively active FXR{alpha}. No such induction was observed in agonist-treated FXR{alpha}-/- mice. Further analysis, that included electrophoretic mobility shift assays, reporter gene activation and chromatin immunoprecipitation, identified two functional FXR{alpha} response elements within intron 2 of the mouse Insig-2 gene. In addition to increasing hepatic Insig-2 protein levels in wild type mice, FXR{alpha} activation also reduced lanosterol 14{alpha}-demethylase mRNA levels and HMG-CoA reductase protein levels. Together these changes likely account for the decrease in cholesterol synthesis observed following activation of FXR in primary hepatocytes. In conclusion, the current study links hepatic FXR{alpha} activation to regulation of genes involved in cholesterol synthesis.


Key words: farnesoid X receptor • GW4064 • Insig-2 • cholesterol

NURSA Molecule Pages Link:

Nuclear Receptors:   SHP  |  FXRα
Ligands:   GW4064



This article has been cited by other articles:


Home page
J EndocrinolHome page
E. De Marinis, C. Martini, A. Trentalance, and V. Pallottini
Sex differences in hepatic regulation of cholesterol homeostasis
J. Endocrinol., September 1, 2008; 198(3): 635 - 643.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society